TransAlta Renewables Announces the Acquisition of 303 MW Portfolio including 274 MW of Wind from TransAlta Corporation
News provided by
Share this article
Share this article
CALGARY, AB, Dec. 23, 2020 /PRNewswire/ - TransAlta Renewables Inc. ( TransAlta Renewables or the Company ) (TSX: RNW) announced that it had entered into definitive agreements for the acquisition of three assets from TransAlta Corporation ( TransAlta ) (TSX: TA) consisting of:
a 100 per cent direct interest in the 207 MW Windrise wind project located in the Municipal District of Willow Creek, Alberta;
a 49 per cent economic interest in the 137 MW Skookumchuck wind facility in operation located across Thurston and Lewis Counties in Washington State; and
Hunter Technology Signs Purchase Agreement – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Sanofi: Availability of the Q4 2020 Memorandum for modelling purposes
Availability of the Q4 2020 Memorandum for modelling purposes
Paris, France - December 17, 2020 - Sanofi announced today that its Q4 2020 Memorandum for modelling purposes is available on the Investors page of the company s website:
https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2020 (https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sanofi.com%2Fen%2Finvestors%2Ffinancial-results-and-events%2Ffinancial-results%2FQ4-results-2020&data=04%7C01%7Carnaud.delepine%40sanofi.com%7C2143b123ba994d8f013208d8a272e36d%7Caca3c8d6aa714e1aa10e03572fc58c0b%7C0%7C0%7C637437961606209332%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=JcOGA60Xs%2FBiitUaZ7q8WGQoX3UX6ERpmt2xrgLJh4Y%3D&reserved=0)
(2)
Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030
A new five-year US$ 25 million (US$ 5 million/year) financial support to prevent and treat Neglected Tropical Diseases
Strong Company commitment to meet the goals of the new WHO NTDs Roadmap and sustainably eliminate sleeping sickness before 2030
20-year partnership outstanding legacy with a decrease of 97% in sleeping sickness cases worldwide
PARIS - December 15, 2020 - Sanofi has signed on December 10
th a renewed partnership agreement with the World Health Organization (WHO), consolidating a 20-year collaboration to fight some of the most Neglected Tropical Diseases (NTDs) and supporting the WHO in its commitment to sustainably eliminate sleeping sickness before 2030.